Background: Obesity is associated with increased prevalence and incidence of asthma, but the mechanism is unknown. Obesity reduces lung volumes, which can increase airway responsiveness, and increases resistive and elastic work of breathing, which can increase dyspnea. Objective: To determine if the intensity of dyspnea due to airway narrowing or if airway responsiveness is increased in obese, non-asthmatic subjects. Subjects: Twenty-three obese (BMI (body mass index) X30 kg m À2 ) and 26 non-obese (BMI o30 kg m À2 ) non-asthmatic subjects, aged between 18 and 70 years. Methods: High-dose methacholine challenge was used to determine the sensitivity and the maximal response to methacholine. Respiratory system resistance (Rrs) and reactance were measured, using the forced oscillation technique, as indicators of resistive and elastic loads during challenge. Perception of dyspnea was measured by the Borg score during challenge. Static lung volumes were measured by body plethysmography. Results: Static lung volumes were reduced in the obese subjects. There were no significant differences in the sensitivity or maximal response to methacholine between obese and non-obese subjects. The magnitude of change in Rrs was similar in both groups, but obese subjects had more negative reactance after challenge (P ¼ 0.002) indicating a greater elastic load. The intensity of dyspnea was greater in obese subjects (P ¼ 0.03). Conclusions: Obesity reduces lung volumes, but does not alter the sensitivity or maximal response to methacholine. However, obese subjects have enhanced perception of dyspnea, associated with greater apparent stiffness of the respiratory system, and may therefore be at greater risk of symptoms.
Introduction
Obesity has been linked with an increased risk of asthma in at least 30 cross-sectional or case-control studies 1 and longitudinal studies have demonstrated that both obesity and weight gain precede the development of asthma. 2 In the majority of these studies, the presence of asthma was detected by questionnaire, using self-reported symptoms or self-reported asthma to define the condition. However, there is little evidence from population studies that obesity is associated with objective markers of asthma such as airway hyperresponsiveness (AHR), [3] [4] [5] [6] [7] airway obstruction 8 or airway inflammation. 9 Asthma is defined by both episodic symptoms and variable airway obstruction. AHR, defined as excessive airway narrowing in response to provoking stimuli, is a marker of the tendency to variable airway obstruction and is a fundamental characteristic of asthma. To understand the association between obesity and asthma, we need to know if obesity can affect symptoms in the absence of any effect on AHR. Airway hyperresponsiveness is characterized both by increased sensitivity to provoking stimuli, defined by a leftward shift in the dose-response curve, and by increased maximal narrowing, defined by an increase in the maximal response plateau on the dose-response curve. 10, 11 Previous studies of the association between obesity and AHR have measured effects on sensitivity. [3] [4] [5] [6] [7] However, obesity is more likely to affect the maximal response, because obesity reduces operating lung volume 12 and breathing at low operating lung volumes is known to induce increased maximal airway narrowing in non-asthmatic subjects. 13, 14 The effect of low lung volume on maximal airway narrowing in obese, non-asthmatic subjects has not been reported. Obesity could have a direct effect on the occurrence of respiratory symptoms by increasing both the resistive and elastic work of breathing. Low lung volumes reduce airway caliber and thus increase airway resistance in the obese. 15, 16 The effects of increased body mass on airway closure and on the chest wall also increase the stiffness of the respiratory system. 15, 17 Increased resistive and elastic loads are chronic effects of obesity, and are unlikely to cause the episodic symptoms that are typical of asthma, but they could increase the sensation of dyspnea associated with acute airway narrowing. A better understanding of the contribution of resistive and elastic loads to dyspnea in the obese, particularly in the presence of acute airway narrowing, would clarify whether obesity could have a direct effect on the occurrence of asthma symptoms. The forced oscillation technique (FOT), which measures the mechanical properties of the respiratory system, can be used to measure resistance and reactance, which are measures of the resistive and elastic loads, respectively, against which patients breathe. The FOT has the advantage that measurements are made during tidal breathing and are thus more relevant to the sensation of dyspnea occurring during normal breathing. The objectives of this study were to determine the effects of obesity on airway responsiveness and dyspnea in healthy, non-asthmatic subjects. We used high-dose methacholine challenge to document full dose-response curves in obese and non-obese subjects, and compared the position of the curve and the maximal response in obese and non-obese subjects. The FOT was used to measure respiratory system resistance (Rsr) and reactance (Xrs) after each dose during the challenge test. We measured the intensity of sensations of dyspnea induced by the bronchial challenge in obese and non-obese subjects, and determined the contribution of physiological changes, including resistive and elastic loads, to the development of dyspnea.
Methods

Subjects
The aim of this study was to determine if the maximal response and dyspnea during a methacholine challenge was increased in obese, non-asthmatic subjects with normal airway responsiveness. To do this, we selected non-asthmatic, non-obese and obese subjects, aged between 18 and 70 years. Non-obese (body mass index (BMI) o30 kg m
À2
) subjects were recruited from staff of the Woolcock Institute of Medical Research, and obese (BMI X30 kg m À2 ) subjects were recruited both from patients of the Metabolism and Obesity Service and Sleep clinics at Royal Prince Alfred Hospital in Sydney and from the staff of the Woolcock Institute of Medical Research. Subjects with diagnosed asthma and/or AHR in response to methacholine challenge and subjects who had significant cardiovascular disease or who currently smoked more than five cigarettes per day were excluded. Exsmokers were included if they had stopped smoking for more than 10 years. The study was approved by the Ethics Review Committee of Royal Prince Alfred Hospital, and all subjects gave written informed consent.
Study design
Subjects were studied during a single visit to the laboratory. Baseline lung volumes and airway resistance, measured by plethysmography, and baseline spirometric function were measured before methacholine challenge and are reported as percent predicted. [18] [19] [20] Atopic status was determined by skin prick tests. Response to methacholine challenge was measured by the change in forced expiratory volume in 1 s (FEV 1 ), and dyspnea was measured by the Borg score. In addition, the FOT was used to measure concurrent changes in respiratory system mechanics during the challenge, to assess their contribution to dyspnea.
Methacholine challenge
Methacholine challenges were performed, with doses from 0.15 to 200 mmol, using a modification of the method of Chai et al. 21, 22 Lung function was measured after each dose, by Rrs and Xrs, using the FOT, and by standard spirometry. Immediately after inhalation of the saline control or methacholine, Rrs and Xrs were measured continuously during 60 s tidal breathing followed by deep inspiration to total lung capacity (TLC), with a passive exhalation back to functional residual capacity (FRC). During the first 60 s period of tidal breathing, subjects indicated the intensity of 'any sensation of uncomfortable breathing' using a modified Borg scale. 23 The Borg scale ranged from 0 to 10, and included descriptors ranging from 'not at all' to 'maximal discomfort'. FEV 1 was measured after the completion of the FOT measurement. Challenge ceased if the FEV 1 decreased by 50% or when the maximum dose was administered. AHR was defined as PD 20 FEV 1 p12.2 mmol methacholine. A maximal response plateau was defined in terms of the % fall in FEV 1 from saline control, as the mean of two values at the end of challenge that differed by less than five percentage points. 10, 22 The position of the dose-response curve was measured in subjects with measurable maximal response plateau by calculating the dose at 50% of the maximal response (ED 50 ).
Body plethysmography
Lung volumes were measured using a constant-volume body plethysmograph that was calibrated daily (Autobox 6200 DL; Sensormedics, Yorba Linda, CA, USA). Subjects supported 
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Respiratory system mechanics Respiratory system mechanics were measured by the FOT (to evaluate the contribution of resistive loads), by Rrs and elastic loads, and by Xrs, to the intensity of dyspnea during challenge. At oscillation frequencies below resonant frequency, Xrs is dominated by the elastance of the system, and thus is a marker of elastic load. The forced oscillation device delivered an oscillation frequency of 6 Hz, and measured flow and pressure at the mouth during tidal breathing. The pressure and flow signals were measured and processed as described previously 24 to calculate the in-phase (resistance) and out-ofphase (reactance) parts of impedance, and provided six measurements of Rrs and Xrs per second. Custom software automatically excluded erroneous and extreme Rrs values, which may occur if the glottis closes or the seal around the mouthpiece is lost during testing. Respiratory system conductance was calculated as the reciprocal of Rrs, and inspiratory capacity, tidal volume and respiratory rate were calculated by the software using the volume trace from the forced oscillation device. Change in inspiratory capacity (IC) was used as a surrogate measure of change in operating lung volume during challenge, although it is recognized that the validity of this measurement is based on the assumption that TLC does not change. Specific respiratory system conductance (sGrs), which reflects airway diameter adjusted for the change in lung volume, was calculated by dividing Grs by the difference between TLC, measured plethysmographically at baseline, and inspiratory capacity, measured by the forced oscillation device.
Data analysis
The perception of airway narrowing during challenge was measured by the progressive change in Borg score during the challenge, as the slope of the regression of Borg score against log methacholine dose in individual subjects. This provided a measure of perception that was independent of any assumptions about the physiological determinants of the sensation of dyspnea. The contribution to the perception score of the maximal changes in FEV 1 , Rrs, sGrs, Xrs and IC during challenge, as well as BMI, were determined by stepwise multiple linear regression in combined data from obese and non-obese subjects. Data are summarized as mean7s.d. unless otherwise specified. Data were analyzed using Analyse-It for Excel (Analyse-it Software Ltd, Leeds, UK). The study power was calculated to detect a difference between groups in maximum response of 7% fall in FEV 1 , on the basis of our previous data. 22 The relationship between BMI and % fall in FEV 1 was analyzed using Pearson's correlation coefficient.
Comparisons between obese and non-obese groups were made by unpaired t-test for continuous variables or by w 2 analysis for categorical variables and P-values p0.05 were considered significant.
Results
Complete data were obtained from 23 obese subjects and 26 non-obese subjects ( , and the remaining were in the normal weight range, with BMI between 20 and 25 kg m À2 . Six non-obese and 12 obese subjects were ex-smokers, and one non-obese and one obese were current irregular smokers (o5 cigarettes per day), but the smoking history, in pack years, was not significantly different. The prevalence of wheeze and shortness of breath on exertion within the last 12 months was greater in the obese group. The small differences between groups in atopy and gender were not statistically significant, and neither atopy nor gender had any effect on any of the study outcomes. There were no significant differences in spirometric function, but Raw values were higher in the obese group. Lung volumes (FRC, TLC and RV, as percent of predicted) were significantly reduced in the obese subjects, but there were no significant differences in vital capacity or RV/TLC ratio. In the obese group, FRC (% predicted) was Obesity, breathlessness and airway responsiveness CM Salome et al significantly correlated with BMI (r ¼ À0.54, P ¼ 0.006) ( Figure 1 ).
Response to methacholine
There were no significant differences in the maximal response to methacholine between obese and non-obese subjects measured by the % fall in FEV 1 (P ¼ 0.80) or sGrs (P ¼ 0.62). Mean dose-response curves for FEV 1 are shown in Figure 2 . One obese and two non-obese subjects did not receive the final dose of 200 mmol methacholine, due to discomfort associated with the challenge, and only one subject reached a 50% fall in FEV 1 by 200 mmol. A clear plateau on the dose-response curve for FEV 1 was observed in 18 obese and 18 non-obese subjects, and there was no significant difference between groups in the level of the plateau (15.777.9 and 18.2712.0% fall in FEV 1 , respectively, P ¼ 0.47). In subjects with a plateau, in whom the ED 50 could be calculated, there was no significant difference in ED 50 between obese and non-obese subjects (6.9, 95% CI: 4.3-11.1 mmol and 10.3, 95% CI: 6.2-17.4 mmol, respectively, P ¼ 0.27). The change in FEV 1 after 200 mmol methacholine was not different between obese and non-obese subjects and was not correlated with FRC as percent predicted in the obese group (r ¼ 0.09, P ¼ 0.67) or in the sample as a whole (r ¼ 0.06, P ¼ 0.71) (Figure 3 ). Both correlations remained non-significant after exclusion of the obvious outlier in the obese group. Furthermore, the change in FEV 1 after 200 mmol methacholine was not correlated with either RV (r ¼ 0.11, P ¼ 0.38) or TLC (r ¼ 0.09, P ¼ 0.54), as percent predicted.
Respiratory system mechanics During tidal breathing, Rrs was increased in the obese, consistent with a smaller airway calibre in obese than in non-obese subjects, both at baseline and after methacholine (Table 2) . However, there were no significant differences in sGrs, indicating that these differences in airway calibre were attributable to differences in lung volumes. During deep inspiration, Rrs decreased in both obese and non-obese subjects, and there was no significant difference in Rrs at TLC between groups either at baseline or after methacholine ( Table 2 ), suggesting that the obese subjects were not limited in their ability to dilate their airways with a deep inspiration. Inspiratory capacity was greater in the obese than in the non-obese at baseline, consistent with the reduction in FRC in the obese. During methacholine challenge, inspiratory capacity decreased in both obese and non-obese subjects (Table 2 ), but the magnitude of the change was greater in the obese subjects. At the end of the challenge, inspiratory capacity had decreased by 22.3712.4% in the obese and 13.0715.1% in the non-obese (P ¼ 0.03). These changes Obesity, breathlessness and airway responsiveness CM Salome et al suggest that the obese subjects developed greater hyperinflation, relative to baseline, than the non-obese subjects, but because the obese started at lower lung volumes, their estimated FRC values at the end of challenge were similar to those of the non-obese subjects. Reactance (Xrs) was more negative in the obese than in the non-obese subjects, both at baseline and after methacholine ( , P ¼ 0.008). There were no significant differences in tidal volumes between obese and nonobese subjects at baseline or after methacholine, but respiratory rate increased in the obese after challenge.
Perception of airway narrowing
The perception of dyspnea, assessed by the rate of change in Borg score during methacholine challenge, was greater in the obese subjects (1.0370.79 vs 0.5170.64, P ¼ 0.03), indicating that the intensity of dyspnea increased to a greater degree among the obese as the challenge progressed. Figure 4 shows mean Borg scores during the challenge in obese and non-obese subjects. Multiple regression analysis, using combined data from obese and non-obese subjects, showed that the rate of increase in dyspnea during the challenge was associated with the magnitude of change in FEV 1 accounting for 35% of the variance, and the magnitude of change in reactance accounting for an additional 6% of the variance (r 2 ¼ 0.41, Po0.0001 for the model). The changes in inspiratory capacity and Rrs were not significant predictors of dyspnea, nor was there any significant contribution from BMI. Thus, since the changes in FEV 1 during the challenge were similar in obese and non-obese subjects, the greater dyspnea during airway narrowing in obese subjects was associated with a greater increase in elastance.
Discussion
This study has shown that there is no significant increase in the level of the maximal response to methacholine in obese, non-asthmatic subjects with normal airway responsiveness, despite reduced operating lung volumes. However, with bronchoconstriction, obese subjects develop increased elastic loads indicated by greater changes in reactance than in nonobese subjects. The obese subjects perceive these increased elastic loads as a greater intensity of dyspnea with increasing airway narrowing. These findings suggest, for the first time, a mechanism whereby asthma-like symptoms might be induced in obese subjects in the absence of any effects of obesity on AHR.
Response to methacholine Obesity had no effect on either the position of the doseresponse curve or the maximal response to methacholine in non-asthmatic subjects. By studying only non-asthmatic subjects, we were able to focus on the effects of obesity alone, independent of any interaction with asthmatic airway pathology, and exclude any effects of symptom-driven factors, such as the effects of medication use on airway responsiveness, which may differ systematically between obese and non-obese subjects. The absence of any effect of Abbreviations: Rrs, respiratory system resistance; Rrs at TLC, respiratory system resistance measured after a deep inspiration to total lung capacity (TLC); sGrs, respiratory system conductance, adjusted for resting lung volume; Xrs, respiratory system reactance. Values are mean7s.d. Figure 4 Mean (95% confidence interval) Borg scores at baseline, after saline control and after each dose of methacholine during bronchial challenge in obese (~) and non-obese (J) subjects.
Obesity, breathlessness and airway responsiveness CM Salome et al obesity on the position of the dose-response curve is consistent with the findings of at least five epidemiological studies, where obesity had no effect on AHR defined by measures of sensitivity. [3] [4] [5] [6] [7] However, the use of high-dose methacholine challenge provides a more complete measure of airway responsiveness by allowing us to document the maximal response, which is an important component of airway responsiveness. 11 Our findings show that obesity, by itself, is not a sufficient condition to alter airway responsiveness to methacholine. This suggests that any effect of obesity on AHR, as has been suggested by at least two population studies, 25, 26 is not a direct effect of obesity alone.
Our finding that low operating lung volumes, due to obesity, had no effect on the maximal response to methacholine differs from the findings of previous studies in lean, non-asthmatic subjects in whom an acute reduction in lung volumes was associated with increased maximal response. 13, 14 The reason for the difference is unclear, but we speculate that differences in lung elastic recoil between obese and non-obese subjects may be a contributing factor. The mechanism of the increased maximal response with reduced lung volume has been attributed to a reduction in lung elastic recoil, which unloads the airway smooth muscle allowing it to shorten excessively when activated. Lung elastic recoil was not measured in this study, but previous studies suggest that it is increased in obesity. 27 It seems likely that the increase in lung elastic recoil in obese subjects can offset the effect of low lung volume, so that there is no unloading of airway smooth muscle, and thus no increase in maximal response.
Perception of dyspnea
Obese subjects experienced more severe dyspnea induced by bronchial challenge and airway narrowing than the nonobese subjects. This finding is consistent with observations in a large study of asthmatics attending an emergency department, 28 where obese subjects reported more severe symptoms than normal weight subjects, despite having higher peak expiratory flow values on admission, suggesting they had a heightened awareness of airway narrowing. The increased intensity of dyspnea in the obese subjects in the present study was not explained by absolute differences in respiratory system resistance at baseline and throughout the challenge. Despite having higher resistance at baseline, there were no significant differences in the baseline Borg score between obese and non-obese. As the challenge progressed, the acute changes in FEV 1 and specific conductance were similar and yet the rate of increase in the intensity of dyspnea was greater in the obese. In studies of the perception of dyspnea induced by bronchial challenge, dyspnea is usually standardized against the change in FEV 1 , and reported as variables such as the perception score at 20% fall in FEV 1 (PS20) 29 or the slope of the regression of dyspnea score against change in FEV 1 . [30] [31] [32] However, in the present study, the Borg scores were standardized against methacholine dose to give a measure of perception that makes no assumption about which physiological stimuli are driving the sensation of dyspnea. We found a strong contribution to dyspnea from the change in FEV 1 , which is consistent with the large number of existing studies that show a close relationship between change in dyspnea and change in FEV 1 . [29] [30] [31] [32] However, in contrast to previous studies, 33 we found no contribution from the change in inspiratory capacity. Instead, the change in reactance was the only other significant contributor to change in dyspnea. Importantly, BMI was not significant in this model, suggesting that there were no other specific obesity-related determinants of dyspnea that were not captured by this model. Since there were no differences between obese and non-obese in the FEV 1 response to challenge, but there were significant differences in reactance, we suggest that these differences in reactance account for the differences between obese and non-obese subjects in the perception of dyspnea. This raises the possibility that the increase in elastic load, indicated by the decrease in reactance, contributes to the increased intensity of dyspnea in obese subjects. Support for this comes from studies showing that subjects exposed to elastic loads characteristically increase their respiratory rate but preserve their tidal volume, as observed in our obese subjects, whereas resistive loads tend to increase tidal volume. 34 Cause of increased elastic loads The source of the increased elastic load in the obese subjects is not known. Respiratory system reactance below resonant frequency is dominated by the system elastance or stiffness, and thus, in the present study, is a good marker of the elastic load. The reactance data indicate that, in the obese subjects, the respiratory system was stiffer at baseline and that stiffness increased at a greater rate during the challenge. The greater baseline stiffness of the respiratory system in the obese could be partly due to greater stiffness of the chest wall and the lung, which is particularly marked above a BMI of approximately 35 kg m
À2
. 27 It is unlikely that methacholine had any direct effect on the chest wall, independent of the changes in inspiratory capacity, and thus the contribution of chest wall stiffness to the changes in reactance during challenge is likely to be small, but cannot be excluded. Reactance is highly sensitive to changes in operating lung volume, so that stiffness increases as lung volume increases. Thus, the greater hyperinflation in the obese during the challenge would partly explain the greater stiffening of the system. However, since dyspnea was correlated with reactance, and not hyperinflation, it is possible that hyperinflation had an exaggerated effect on system stiffness in the obese. Changes in hyperinflation, measured by inspiratory capacity, are based on the assumption that TLC is unchanged, but lung volumes were not measured after challenge in this study and thus the effects on TLC are not known. Airway closure during challenge may also have been Obesity, breathlessness and airway responsiveness CM Salome et al an important contributor to the increase in elastic load. Previous studies show that in extreme obesity tidal breathing occurs at volumes near to the closing volume, 35 and it is possible that airway closure could be more easily induced by methacholine challenge in the obese. Further studies, which include direct measurements of changes in lung volumes and in the frequency dependence of elastance, may provide more specific information about the physiological changes underlying the increase in respiratory system stiffness during bronchoconstriction in the obese. The difference in reactance between obese and non-obese subjects is in keeping with other evidence that suggests that there are differences in respiratory system mechanics that are not reflected in FEV 1 .
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Obesity and asthma Our findings suggest a mechanism whereby asthma might be induced in obese subjects, in the absence of any direct effects of obesity on AHR. It has been suggested that the excess wheezing illness in the obese is not due to 'real' asthma, but is simply a misdiagnosis of excessive breathlessness. 6, 8 However, it is possible that obesity could cause 'real' asthma, not by increasing AHR, but by inducing symptoms in people with previously asymptomatic AHR. We have shown that if airway narrowing occurs in otherwise healthy, obese individuals, it causes more severe dyspnea because of the added elastic loads on their respiratory system. We hypothesize that subjects who are predisposed to episodes of airway narrowing, such as those with asymptomatic AHR, would be more likely to experience symptoms during airway narrowing if they were obese. This hypothesis is consistent with observations made by Hancox et al., 7 who have shown that while obesity does not increase the risk of developing AHR, it does increase the risk of developing asthma symptoms, with the greatest risk for development of symptoms in the presence of AHR. Two other population studies have also shown that obesity is a risk for the combination of symptoms plus AHR. 36, 37 Up to 15% of the adult population have asymptomatic AHR, 38 representing a substantial population potentially at risk of developing symptoms in the presence of obesity.
In conclusion, this study has shown that obesity, by itself, is not sufficient to alter airway responsiveness to methacholine in non-asthmatic subjects with normal airway responsiveness. However, during airway narrowing, obese subjects significantly experience more severe dyspnea, which is associated with the development of greater system elastance. These findings do not provide any evidence to support the hypothesis that the simple mechanical effects of obesity induce changes in the airways that increase airway responsiveness. Instead, they suggest that excess respiratory symptoms and asthma in obese individuals might be explained by an increased sensation of dyspnea associated with greater respiratory system stiffness during airway narrowing. These observations raise the possibility that changes in respiratory system stiffness during bronchial challenge constitute a different form of AHR than that measured by standard spirometric variables.
